Diabetes Mellitus: Artigos de Revisão (Diabetes Mellitus: Online Review Articles)

■ Management of hyperglycaemia in type 2 diabetes

A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

M J Davies, D A D´Alessio, J Fradkin et al

Diabetologia 2018, vol 61: 2461-2498

https://link.springer.com/article/10.1007/s00125-018-4729-5

■ 2018 Clinical practice guidelines type 1 diabetes in children and adolescents diabetes Canada clinical practice guidelines expert committee

D K Wherrett, J Ho, C Huot et al

Can J Diabetes 2018, vol 42: S234-S246

https://guidelines.diabetes.ca/docs/cpg/Ch34-Type-1-Diabetes-in-Children-and-Adolescents.pdf

■ Diabetes childhood and adolescence: A guideline-based approach to diagnosis, treatment, and follow-up

Ralph Ziegler, Andreas Neu

Dtsch Arztebl Int. 2018, vol 115(9): 146–156

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876549/

■ 2019 Guidelines on the management of diabetic patients: A position paper Diabetes Poland

Aleksandra Araszkiewicz, Elżbieta Bandurska-Stankiewicz, Andrzej Budzyński et al

Clinical Diabetology 2019, vol 8 (1): 1-95

https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2019.0001/47304

■ Standards of Polish Society of Gynecologists and Obstetrician in management of women with diabetes

Wender-Ożegowska E, Bomba-Opoń D, Brązert J et al

Ginekol Pol. 2018;89(6):341-350

https://journals.viamedica.pl/ginekologia_polska/article/view/GP.a2018.0059/44785

■ Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM).

Faludi, André Arpad et al.

Arq. Bras. Cardiol., Dez 2017, vol.109, no.6, suppl.1, p.1-31

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2017001600001&lng=pt&nrm=iso

■ Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type of insulin in type 1 and type 2 diabetes in low-resource settings

G Roglic, S L Norris

Ann Intern Med 2018, vol 169 (6): 394-397

https://annals.org/aim/fullarticle/2698900/medicines-treatment-intensification-type-2-diabetes-type-insulin-type-1

■ Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the American College of Physicians

A Qaseem M J Barry , L L Humphrey et al

Ann Intern Med 2017, vol 166 (4): 279-290

https://annals.org/aim/fullarticle/2595888/oral-pharmacologic-treatment-type-2-diabetes-mellitus-clinical-practice-guideline

■ The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: A report from EUROASPIRE IV: A survey from the European Society of Cardiology

Bahira Shahim, Dirk De Bacquer, Guy De Backer et al

Diabetes Care. 2017 Sep; 40(9): 1233–1240

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566283/

■ The quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus: a systematic review using the AGREE II instrument

Meha Bhatt, Ahmed Nahari, Pei-Wen Wang et al

Syst Rev.2018 vol ; 7: 193.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238336/

■ EADSG guidelines: Insulin therapy in diabetes

Bahendeka Silver, Kaushik Ramaiya, Swai Babu Andrew et al

Diabetes Ther. 2018 Apr; 9(2): 449–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104264/

■ RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus2017

Sarita Bajaj

Int J Diabetes Dev Ctries. 2018, vol 38(Suppl 1): 1–115

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838201/

■ Expert Opinion: patient selection for premixed insulin formulations in diabetes care

Sanjay Kalra, Leszek Czupryniak, Gary Kilov, et al

Diabetes Ther. 2018 Dec; 9(6): 2185–2199.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250631/

■ Japanese clinical practice guideline for diabetes 2016

Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa et al

J Diabetes Investig. 2018 May; 9(3): 657–697

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934251/

■ Gestational diabetes mellitus (GDM) – Diagnosis, treatment and follow-up. Guidelines of the DDG and DGGG (S3 level, AWMF Registry Number 057/008, February 2018)

Schäfer-Graf UM, Gembruch U, Kainer F et al

Geburtshilfe Frauenheilkd. 2018 Dec;78(12):1219-1231

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301211/

■ Gestational diabetes mellitus 2018 guidelines: an update

Mishra S, Bhadoria AS, Kishore S, Kumar R.

J Family Med Prim Care. 2018 Nov-Dec;7(6):1169-1172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293929/

■ Update on the management of diabetic dyslipidemia

I Martín-Timón, C Sevillano-Collantes, M García-Domínguez et al

European Medical Journal nov 2018

https://www.emjreviews.com/diabetes/article/update-on-the-management-of-diabetic-dyslipidaemia/

■ Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherencefrom the Swedish National Diabetes Register

Sofia Axia Karlsson, Stefan Franzén, Ann-Marie Svensson et al

BMC Health Serv Res. 2018; vol 18: 900

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260691/

■ 2017 National Standards for Diabetes Self-Management Education and Support

Joni Beck, Deborah A. Greenwood, Lori Blanton et al

Diabetes Spectr. 2017 Nov; 30(4): 301–314

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687107/

■ Pharmacologic management of chronic neuropathic pain: review of the Canadian Pain Society consensus statement

A Mu, E Weinberg, D E Moulin, H Clarke

Can Fam Phycian2017, vol 63 (11): 844-852

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685445/

by Dr Paulo Fernando Leite